NeuroMetrix, Inc. (NURO)
4.58
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 16:00
NeuroMetrix Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 0.0026M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.0026M |
| March 31, 2024 | 1.471M |
| December 31, 2023 | 1.624M |
| September 30, 2023 | 0.0014M |
| June 30, 2023 | 0.7001M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 1.913M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0078M |
| March 31, 2022 | 1.943M |
| December 31, 2021 | -0.1223M |
| September 30, 2021 | 15.88M |
| June 30, 2021 | 3.816M |
| March 31, 2021 | -0.0258M |
| December 31, 2020 | 0.0158M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 3.698M |
| March 31, 2020 | 0.4535M |
| December 31, 2019 | 0.0076M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0075M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0094M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.0093M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 3.340M |
| September 30, 2017 | 3.257M |
| June 30, 2017 | 0.0104M |
| March 31, 2017 | 6.302M |
| December 31, 2016 | 0.0167M |
| September 30, 2016 | -0.069M |
| June 30, 2016 | 6.796M |
| March 31, 2016 | -0.0767M |
| December 31, 2015 | 6.825M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 10.11M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0139M |
| September 30, 2014 | -0.0421M |
| June 30, 2014 | 7.960M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 2.642M |
| September 30, 2013 | -0.0711M |
| June 30, 2013 | 4.571M |
| March 31, 2013 | -0.0053M |
| December 31, 2012 | 0.0063M |
| September 30, 2012 | -0.0051M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | 17.31B |
| Aethlon Medical, Inc. | -0.1965M |
| ABVC BioPharma, Inc. | -0.3422M |
| Adagio Medical Holdings, Inc. | 0.00 |
| Autonomix Medical, Inc. | -0.035M |